These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 2886594)
21. [Opioid receptors altered binding nature in guinea-pig brain following the development of morphine dependence]. Ohta S; Niwa M; Nozaki M; Hattori M; Shimonaka H; Dohi S Masui; 1995 Nov; 44(11):1452-7. PubMed ID: 8544279 [TBL] [Abstract][Full Text] [Related]
22. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans. Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286 [TBL] [Abstract][Full Text] [Related]
23. [3H] dynorphin binding to guinea pig and rat brain. Young E; Walker JM; Houghten R; Akil H Life Sci; 1983; 33 Suppl 1():287-90. PubMed ID: 6141490 [TBL] [Abstract][Full Text] [Related]
24. CI-977, a novel and selective agonist for the kappa-opioid receptor. Hunter JC; Leighton GE; Meecham KG; Boyle SJ; Horwell DC; Rees DC; Hughes J Br J Pharmacol; 1990 Sep; 101(1):183-9. PubMed ID: 2178014 [TBL] [Abstract][Full Text] [Related]
25. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes. Werling LL; Brown SR; Puttfarcken P; Cox BM Mol Pharmacol; 1986 Aug; 30(2):90-5. PubMed ID: 3016504 [TBL] [Abstract][Full Text] [Related]
26. Mu-opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [35S]GTPgammaS binding assays. Márki A; Monory K; Otvös F; Tóth G; Krassnig R; Schmidhammer H; Traynor JR; Roques BP; Maldonado R; Borsodi A Eur J Pharmacol; 1999 Oct; 383(2):209-14. PubMed ID: 10585536 [TBL] [Abstract][Full Text] [Related]
27. PD117302: a selective agonist for the kappa-opioid receptor. Clark CR; Birchmore B; Sharif NA; Hunter JC; Hill RG; Hughes J Br J Pharmacol; 1988 Mar; 93(3):618-26. PubMed ID: 2836012 [TBL] [Abstract][Full Text] [Related]
28. Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Goldstein A; Naidu A Mol Pharmacol; 1989 Aug; 36(2):265-72. PubMed ID: 2549383 [TBL] [Abstract][Full Text] [Related]
29. Selective changes in mu opioid receptor properties induced by chronic morphine exposure. Werling LL; McMahon PN; Cox BM Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6393-7. PubMed ID: 2548212 [TBL] [Abstract][Full Text] [Related]
31. Endogenous ligands for sigma opioid receptors in the brain ("sigmaphin"): evidence from binding assays. Su TP; Weissman AD; Yeh SY Life Sci; 1986 Jun; 38(24):2199-210. PubMed ID: 3012236 [TBL] [Abstract][Full Text] [Related]
32. Demonstration of the heterogeneity of the kappa-opioid receptors in guinea-pig cerebellum using selective and nonselective drugs. Tiberi M; Magnan J Eur J Pharmacol; 1990 Jun; 188(6):379-89. PubMed ID: 2164939 [TBL] [Abstract][Full Text] [Related]
33. High-performance liquid chromatographic determination of trimebutine and its major metabolite, N-monodesmethyl trimebutine, in rat and human plasma. Joo EH; Chang WI; Oh I; Shin SC; Na HK; Lee YB J Chromatogr B Biomed Sci Appl; 1999 Feb; 723(1-2):239-46. PubMed ID: 10080651 [TBL] [Abstract][Full Text] [Related]
34. Interaction of selective mu and delta ligands with the kappa 2 subtype of opiate binding sites. Gouarderes C; Attali B; Audigier Y; Cros J Life Sci; 1983; 33 Suppl 1():175-8. PubMed ID: 6319857 [TBL] [Abstract][Full Text] [Related]
35. Opioid agonist and antagonist bivalent ligands. The relationship between spacer length and selectivity at multiple opioid receptors. Portoghese PS; Larson DL; Sayre LM; Yim CB; Ronsisvalle G; Tam SW; Takemori AE J Med Chem; 1986 Oct; 29(10):1855-61. PubMed ID: 3020244 [TBL] [Abstract][Full Text] [Related]
36. Receptor binding and biological activity of the dermorphin analog Tyr-D-Arg(2)-Phe-Sar (TAPS). Vonhof S; Barone FC; Price WJ; Paakkari P; Millison JH; Feuerstein GZ; Sirén AK Eur J Pharmacol; 2001 Mar; 416(1-2):83-93. PubMed ID: 11282116 [TBL] [Abstract][Full Text] [Related]
37. Solubilization and characterization of mu, delta, and kappa opioid binding sites from guinea pig brain: physical separation of kappa receptors. Itzhak Y; Hiller JM; Simon EJ Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4217-21. PubMed ID: 6330751 [TBL] [Abstract][Full Text] [Related]
38. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists. Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176 [TBL] [Abstract][Full Text] [Related]
39. Opioid agonist affinity in the guinea-pig ileum and mouse vas deferens. Porreca F; LoPresti D; Ward SJ Eur J Pharmacol; 1990 Apr; 179(1-2):129-39. PubMed ID: 2163849 [TBL] [Abstract][Full Text] [Related]
40. Comparative neuroanatomical distribution of the kappa and mu opioid receptors in guinea pig brain sections. Lahti RA; Mickelson MM; Jodelis KS; McCall JM Eur J Pharmacol; 1989 Aug; 166(3):563-6. PubMed ID: 2553438 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]